Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Alternative polyadenylation factors link cell cycle to migration.

Mitra M, Johnson EL, Swamy VS, Nersesian LE, Corney DC, Robinson DG, Taylor DG, Ambrus AM, Jelinek D, Wang W, Batista SL, Coller HA.

Genome Biol. 2018 Oct 25;19(1):176. doi: 10.1186/s13059-018-1551-9.

2.

A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.

Robinson DG, Gallego JA, John M, Hanna LA, Zhang JP, Birnbaum ML, Greenberg J, Naraine M, Peters BD, McNamara RK, Malhotra AK, Szeszko PR.

Schizophr Res. 2018 Sep 18. pii: S0920-9964(18)30556-5. doi: 10.1016/j.schres.2018.09.006. [Epub ahead of print]

PMID:
30241990
3.

Low-Level Nighttime Light Therapy for Age-Related Macular Degeneration: A Randomized Clinical Trial.

Robinson DG, Margrain TH, Dunn MJ, Bailey C, Binns AM.

Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4531-4541. doi: 10.1167/iovs.18-24284.

PMID:
30208421
4.

Frequency specific resting state functional abnormalities in psychosis.

Gohel S, Gallego JA, Robinson DG, DeRosse P, Biswal B, Szeszko PR.

Hum Brain Mapp. 2018 Nov;39(11):4509-4518. doi: 10.1002/hbm.24302. Epub 2018 Aug 30.

PMID:
30160325
5.

Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.

Mueser KT, Meyer-Kalos PS, Glynn SM, Lynde DW, Robinson DG, Gingerich S, Penn DL, Cather C, Gottlieb JD, Marcy P, Wiseman JL, Potretzke S, Brunette MF, Schooler NR, Addington J, Rosenheck RA, Estroff SE, Kane JM.

Schizophr Res. 2018 Aug 20. pii: S0920-9964(18)30507-3. doi: 10.1016/j.schres.2018.08.015. [Epub ahead of print]

PMID:
30139553
6.

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression.

Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, Hui CLM, Chen EYH, Valencia M, Juarez F, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, Marcy P, Addington J, Estroff SE, Robinson J, Penn D, Severe JB, Kane JM.

JAMA Psychiatry. 2018 Jun 1;75(6):555-565. doi: 10.1001/jamapsychiatry.2018.0623.

PMID:
29800949
7.

Frontal lobe functioning during a simple response conflict task in first-episode psychosis and its relationship to treatment response.

Shafritz KM, Ikuta T, Greene A, Robinson DG, Gallego J, Lencz T, DeRosse P, Kingsley PB, Szeszko PR.

Brain Imaging Behav. 2018 May 9. doi: 10.1007/s11682-018-9876-2. [Epub ahead of print]

PMID:
29744804
8.

Turnover of Tonoplast Proteins.

Ivanov R, Robinson DG.

Plant Physiol. 2018 May;177(1):10-11. doi: 10.1104/pp.18.00322. No abstract available.

PMID:
29720533
9.

Auxin and Vesicle Traffic.

Robinson DG, Hawes C, Hillmer S, Jürgens G, Schwechheimer C, Stierhof YD, Viotti C.

Plant Physiol. 2018 Mar;176(3):1884-1888. doi: 10.1104/pp.17.01510. Epub 2018 Mar 6. No abstract available.

PMID:
29630496
10.

Retromer and VSR Recycling: A Red Herring?

Robinson DG.

Plant Physiol. 2018 Jan;176(1):483-484. doi: 10.1104/pp.17.01502. No abstract available.

PMID:
29317525
11.

Investigation of superior longitudinal fasciculus fiber complexity in recent onset psychosis.

Szeszko PR, Tan ET, Uluğ AM, Kingsley PB, Gallego JA, Rhindress K, Malhotra AK, Robinson DG, Marinelli L.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:114-121. doi: 10.1016/j.pnpbp.2017.10.019. Epub 2017 Oct 28.

PMID:
29111405
12.

Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.

Robinson DG, Schooler NR, Correll CU, John M, Kurian BT, Marcy P, Miller AL, Pipes R, Trivedi MH, Kane JM.

Am J Psychiatry. 2018 Feb 1;175(2):169-179. doi: 10.1176/appi.ajp.2017.16080919. Epub 2017 Sep 15.

13.

Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis.

Sint K, Rosenheck R, Robinson DG, Schooler NR, Marcy P, Kane JM, Mueser KT, Lin H; other RAISE ETP Investigators.

Schizophr Res. 2018 May;195:481-487. doi: 10.1016/j.schres.2017.08.029. Epub 2017 Aug 25.

PMID:
28844431
14.

Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study.

Nagendra A, Schooler NR, Kane JM, Robinson DG, Mueser KT, Estroff SE, Addington J, Marcy P, Penn DL.

Schizophr Res. 2018 Mar;193:64-68. doi: 10.1016/j.schres.2017.06.038. Epub 2017 Jul 11.

PMID:
28709773
15.

Demographic and clinical correlates of substance use disorders in first episode psychosis.

Brunette MF, Mueser KT, Babbin S, Meyer-Kalos P, Rosenheck R, Correll CU, Cather C, Robinson DG, Schooler NR, Penn DL, Addington J, Estroff SE, Gottlieb J, Glynn SM, Marcy P, Robinson J, Kane JM.

Schizophr Res. 2018 Apr;194:4-12. doi: 10.1016/j.schres.2017.06.039. Epub 2017 Jul 8.

PMID:
28697856
16.

Perceived Autonomy Support in the NIMH RAISE Early Treatment Program.

Browne J, Penn DL, Bauer DJ, Meyer-Kalos P, Mueser KT, Robinson DG, Addington J, Schooler NR, Glynn SM, Gingerich S, Marcy P, Kane JM.

Psychiatr Serv. 2017 Sep 1;68(9):916-922. doi: 10.1176/appi.ps.201600480. Epub 2017 Jun 1.

PMID:
28566027
17.

Incomes and Outcomes: Social Security Disability Benefits in First-Episode Psychosis.

Rosenheck RA, Estroff SE, Sint K, Lin H, Mueser KT, Robinson DG, Schooler NR, Marcy P, Kane JM; RAISE-ETP Investigators.

Am J Psychiatry. 2017 Sep 1;174(9):886-894. doi: 10.1176/appi.ajp.2017.16111273. Epub 2017 Apr 21.

PMID:
28427286
18.

Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.

Lyall AE, Pasternak O, Robinson DG, Newell D, Trampush JW, Gallego JA, Fava M, Malhotra AK, Karlsgodt KH, Kubicki M, Szeszko PR.

Mol Psychiatry. 2018 Mar;23(3):701-707. doi: 10.1038/mp.2017.43. Epub 2017 Mar 28.

19.

Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia.

Sarpal DK, Robinson DG, Fales C, Lencz T, Argyelan M, Karlsgodt KH, Gallego JA, John M, Kane JM, Szeszko PR, Malhotra AK.

Neuropsychopharmacology. 2017 Oct;42(11):2214-2221. doi: 10.1038/npp.2017.55. Epub 2017 Mar 15.

20.

Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.

Rhindress K, Robinson DG, Gallego JA, Wellington R, Malhotra AK, Szeszko PR.

Psychol Med. 2017 Jul;47(10):1706-1718. doi: 10.1017/S0033291717000137. Epub 2017 Feb 14.

PMID:
28193301
21.

Widespread changes in mRNA stability contribute to quiescence-specific gene expression patterns in a fibroblast model of quiescence.

Johnson EL, Robinson DG, Coller HA.

BMC Genomics. 2017 Feb 1;18(1):123. doi: 10.1186/s12864-017-3521-0.

22.

Trauma advanced practice provider programme development in an academic setting to optimize care coordination.

Woodfall MC, Browder TD, Alfaro JM, Claudius MA, Chan GK, Robinson DG, Spain DA.

Trauma Surg Acute Care Open. 2017 Jan 27;2(1):e000068. doi: 10.1136/tsaco-2016-000068. eCollection 2017.

23.

Psychological well-being and mental health recovery in the NIMH RAISE early treatment program.

Browne J, Penn DL, Meyer-Kalos PS, Mueser KT, Estroff SE, Brunette MF, Correll CU, Robinson J, Rosenheck RA, Schooler N, Robinson DG, Addington J, Marcy P, Kane JM.

Schizophr Res. 2017 Jul;185:167-172. doi: 10.1016/j.schres.2016.11.032. Epub 2016 Nov 29.

24.

Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income.

Rosenheck R, Mueser KT, Sint K, Lin H, Lynde DW, Glynn SM, Robinson DG, Schooler NR, Marcy P, Mohamed S, Kane JM.

Schizophr Res. 2017 Apr;182:120-128. doi: 10.1016/j.schres.2016.09.024. Epub 2016 Sep 23.

PMID:
27667369
25.

mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge.

Ben-Zeev D, Scherer EA, Gottlieb JD, Rotondi AJ, Brunette MF, Achtyes ED, Mueser KT, Gingerich S, Brenner CJ, Begale M, Mohr DC, Schooler N, Marcy P, Robinson DG, Kane JM.

JMIR Ment Health. 2016 Jul 27;3(3):e34. doi: 10.2196/mental.6348.

26.

Receptor-mediated sorting of soluble vacuolar proteins: myths, facts, and a new model.

Robinson DG, Neuhaus JM.

J Exp Bot. 2016 Aug;67(15):4435-49. doi: 10.1093/jxb/erw222. Epub 2016 Jun 4. Review.

PMID:
27262127
27.

Health Technology Intervention After Hospitalization for Schizophrenia: Service Utilization and User Satisfaction.

Baumel A, Correll CU, Hauser M, Brunette M, Rotondi A, Ben-Zeev D, Gottlieb JD, Mueser KT, Achtyes ED, Schooler NR, Robinson DG, Gingerich S, Marcy P, Meyer-Kalos P, Kane JM.

Psychiatr Serv. 2016 Sep 1;67(9):1035-8. doi: 10.1176/appi.ps.201500317. Epub 2016 Jun 1.

PMID:
27247171
28.

Early Mortality Among People With Schizophrenia.

Robinson DG.

Am J Psychiatry. 2016 Jun 1;173(6):554-5. doi: 10.1176/appi.ajp.2016.16030334. No abstract available.

PMID:
27245185
29.

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU.

Schizophr Bull. 2016 Nov;42(6):1418-1437. doi: 10.1093/schbul/sbw058. Epub 2016 May 23. Review.

30.

Yes, We Have an Inflation of Reviews: But of the Wrong Kind!

Robinson DG.

Front Plant Sci. 2016 Apr 26;7:494. doi: 10.3389/fpls.2016.00494. eCollection 2016. No abstract available.

31.

Response to Amos: Addressing Purported Methodological Flaws in RAISE-ETP Results.

Kane JM, Robinson DG, Schooler NR, Lin H, Rosenheck RA, Heinssen RK; RAISE-ETP Study Group.

Am J Psychiatry. 2016 May 1;173(5):535-6. doi: 10.1176/appi.ajp.2016.15111427r. No abstract available.

PMID:
27133408
32.

Age and Sex Effects on White Matter Tracts in Psychosis from Adolescence through Middle Adulthood.

Schwehm A, Robinson DG, Gallego JA, Karlsgodt KH, Ikuta T, Peters BD, Malhotra AK, Szeszko PR.

Neuropsychopharmacology. 2016 Sep;41(10):2473-80. doi: 10.1038/npp.2016.47. Epub 2016 Apr 12.

33.

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.

Drögemöller BI, Emsley R, Chiliza B, van der Merwe L, Wright GE, Daya M, Hoal E, Malhotra AK, Lencz T, Robinson DG, Zhang JP, Asmal L, Niehaus DJ, Warnich L.

Pharmacogenet Genomics. 2016 May;26(5):235-42. doi: 10.1097/FPC.0000000000000213.

PMID:
26928376
34.

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.

Rosenheck R, Leslie D, Sint K, Lin H, Robinson DG, Schooler NR, Mueser KT, Penn DL, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Severe J, Rupp A, Schoenbaum M, Kane JM.

Schizophr Bull. 2016 Jul;42(4):896-906. doi: 10.1093/schbul/sbv224. Epub 2016 Jan 31.

35.

Coordinated Technology-Delivered Treatment to Prevent Rehospitalization in Schizophrenia: A Novel Model of Care.

Brunette MF, Rotondi AJ, Ben-Zeev D, Gottlieb JD, Mueser KT, Robinson DG, Achtyes ED, Gingerich S, Marcy P, Schooler NR, Meyer-Kalos P, Kane JM.

Psychiatr Serv. 2016 Apr 1;67(4):444-7. doi: 10.1176/appi.ps.201500257. Epub 2016 Jan 4.

PMID:
26725297
36.

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Meyer-Kalos PS, Gottlieb JD, Glynn SM, Lynde DW, Pipes R, Kurian BT, Miller AL, Azrin ST, Goldstein AB, Severe JB, Lin H, Sint KJ, John M, Heinssen RK.

Am J Psychiatry. 2016 Apr 1;173(4):362-72. doi: 10.1176/appi.ajp.2015.15050632. Epub 2015 Oct 20.

37.

Unconventional protein secretion in plants: a critical assessment.

Robinson DG, Ding Y, Jiang L.

Protoplasma. 2016 Jan;253(1):31-43. doi: 10.1007/s00709-015-0887-1. Epub 2015 Sep 26. Review.

PMID:
26410830
38.

Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.

Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, Malhotra AK.

Schizophr Bull. 2015 Nov;41(6):1237-47. doi: 10.1093/schbul/sbv120. Epub 2015 Sep 25.

39.

Exocyst-Positive Organelles and Autophagosomes Are Distinct Organelles in Plants.

Lin Y, Ding Y, Wang J, Shen J, Kung CH, Zhuang X, Cui Y, Yin Z, Xia Y, Lin H, Robinson DG, Jiang L.

Plant Physiol. 2015 Nov;169(3):1917-32. doi: 10.1104/pp.15.00953. Epub 2015 Sep 10.

40.

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.

Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang JP, Lopez L, Braga RJ, Sevy SM, Addington J, Kellner CH, Tohen M, Naraine M, Bennett N, Greenberg J, Lencz T, Correll CU, Kane JM, Malhotra AK.

Schizophr Bull. 2015 Nov;41(6):1227-36. doi: 10.1093/schbul/sbv125. Epub 2015 Sep 3.

41.

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.

Zhang JP, Robinson DG, Gallego JA, John M, Yu J, Addington J, Tohen M, Kane JM, Malhotra AK, Lencz T.

Schizophr Bull. 2015 Nov;41(6):1248-55. doi: 10.1093/schbul/sbv116. Epub 2015 Aug 28.

42.

Responses to Tobacco Smoking-Related Health Messages in Young People With Recent-Onset Schizophrenia.

Coletti DJ, Brunette M, John M, Kane JM, Malhotra AK, Robinson DG.

Schizophr Bull. 2015 Nov;41(6):1256-65. doi: 10.1093/schbul/sbv122. Epub 2015 Aug 27.

43.

Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.

Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, Weissman N, Gallego JA, Kane JM, Lencz T, Malhotra AK.

Am J Psychiatry. 2016 Jan;173(1):69-77. doi: 10.1176/appi.ajp.2015.14121571. Epub 2015 Aug 28.

44.

Applications of temporal kernel canonical correlation analysis in adherence studies.

John M, Lencz T, Ferbinteanu J, Gallego JA, Robinson DG.

Stat Methods Med Res. 2017 Oct;26(5):2437-2454. doi: 10.1177/0962280215598805. Epub 2015 Aug 20.

45.

Endocytosis: Is There Really a Recycling from Late Endosomes?

Robinson DG.

Mol Plant. 2015 Oct 5;8(10):1554-6. doi: 10.1016/j.molp.2015.07.005. Epub 2015 Jul 21. No abstract available.

46.

The invasive land planarian Platydemus manokwari (Platyhelminthes, Geoplanidae): records from six new localities, including the first in the USA.

Justine JL, Winsor L, Barrière P, Fanai C, Gey D, Han AW, La Quay-Velázquez G, Lee BP, Lefevre JM, Meyer JY, Philippart D, Robinson DG, Thévenot J, Tsatsia F.

PeerJ. 2015 Jun 23;3:e1037. doi: 10.7717/peerj.1037. eCollection 2015.

47.

A nested parallel experiment demonstrates differences in intensity-dependence between RNA-seq and microarrays.

Robinson DG, Wang JY, Storey JD.

Nucleic Acids Res. 2015 Nov 16;43(20):e131. doi: 10.1093/nar/gkv636. Epub 2015 Jun 30.

48.

Response to Saraga.

Robinson DG, Schooler NR, Kane JM.

Am J Psychiatry. 2015 Jun;172(6):588. doi: 10.1176/appi.ajp.2015.14121589r. No abstract available.

PMID:
26029809
49.

Vesicles versus Tubes: Is Endoplasmic Reticulum-Golgi Transport in Plants Fundamentally Different from Other Eukaryotes?

Robinson DG, Brandizzi F, Hawes C, Nakano A.

Plant Physiol. 2015 Jun;168(2):393-406. doi: 10.1104/pp.15.00124. Epub 2015 Apr 16. Review.

50.

The RAISE early treatment program for first-episode psychosis: background, rationale, and study design.

Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, Rosenheck RA, Addington J, Estroff SE, Robinson J, Penn DL, Robinson DG.

J Clin Psychiatry. 2015 Mar;76(3):240-6. doi: 10.4088/JCP.14m09289.

PMID:
25830446

Supplemental Content

Loading ...
Support Center